181 related articles for article (PubMed ID: 8314986)
21. Mycoplasma agassizii in Morafka's desert tortoise (Gopherus morafkai) in Mexico.
Berry KH; Brown MB; Vaughn M; Gowan TA; Hasskamp MA; Torres MC
J Wildl Dis; 2015 Jan; 51(1):89-100. PubMed ID: 25375948
[TBL] [Abstract][Full Text] [Related]
22. Surveillance for upper respiratory tract disease and Mycoplasma in free-ranging gopher tortoises (Gopherus polyphemus) in Georgia, USA.
McGuire JL; Smith LL; Guyer C; Lockhart JM; Lee GW; Yabsley MJ
J Wildl Dis; 2014 Oct; 50(4):733-44. PubMed ID: 25098305
[TBL] [Abstract][Full Text] [Related]
23. Improved enzyme-linked immunosorbent assay to reveal Mycoplasma agassizii exposure: a valuable tool in the management of environmentally sensitive tortoise populations.
Wendland LD; Zacher LA; Klein PA; Brown DR; Demcovitz D; Littell R; Brown MB
Clin Vaccine Immunol; 2007 Sep; 14(9):1190-5. PubMed ID: 17626160
[TBL] [Abstract][Full Text] [Related]
24. Mycoplasmosis and upper respiratory tract disease of tortoises: a review and update.
Jacobson ER; Brown MB; Wendland LD; Brown DR; Klein PA; Christopher MM; Berry KH
Vet J; 2014 Sep; 201(3):257-64. PubMed ID: 24951264
[TBL] [Abstract][Full Text] [Related]
25. Host contact and shedding patterns clarify variation in pathogen exposure and transmission in threatened tortoise Gopherus agassizii: implications for disease modelling and management.
Aiello CM; Nussear KE; Esque TC; Emblidge PG; Sah P; Bansal S; Hudson PJ
J Anim Ecol; 2016 May; 85(3):829-42. PubMed ID: 26935482
[TBL] [Abstract][Full Text] [Related]
26. Mycoplasma agassizii sp. nov., isolated from the upper respiratory tract of the desert tortoise (Gopherus agassizii) and the gopher tortoise (Gopherus polyphemus).
Brown MB; Brown DR; Klein PA; McLaughlin GS; Schumacher IM; Jacobson ER; Adams HP; Tully JG
Int J Syst Evol Microbiol; 2001 Mar; 51(Pt 2):413-418. PubMed ID: 11321087
[TBL] [Abstract][Full Text] [Related]
27. Molecular characterization of Pasteurella testudinis isolated from desert tortoises (Gopherus agassizii) with and without upper respiratory tract disease.
Snipes KP; Kasten RW; Calagoan JM; Boothby JT
J Wildl Dis; 1995 Jan; 31(1):22-9. PubMed ID: 7563420
[TBL] [Abstract][Full Text] [Related]
28. COMPARISON OF CURRENT METHODS FOR THE DETECTION OF CHRONIC MYCOPLASMAL URTD IN WILD POPULATIONS OF THE MOJAVE DESERT TORTOISE (GOPHERUS AGASSIZII).
Sandmeier FC; Weitzman CL; Maloney KN; Tracy CR; Nieto N; Teglas MB; Hunter KW; DuPré S; Gienger CM; Tuma MW
J Wildl Dis; 2017 Jan; 53(1):91-101. PubMed ID: 27788056
[TBL] [Abstract][Full Text] [Related]
29. A quantitative PCR method for assessing the presence of Pasteurella testudinis DNA in nasal lavage samples from the desert tortoise (Gopherus agassizii).
duPre' SA; Tracy CR; Sandmeier FC; Hunter KW
J Microbiol Methods; 2012 Dec; 91(3):443-7. PubMed ID: 23000631
[TBL] [Abstract][Full Text] [Related]
30. Impacts of upper respiratory tract disease on olfactory behavior of the Mojave desert tortoise.
Germano J; Van Zerr VE; Esque TC; Nussear KE; Lamberski N
J Wildl Dis; 2014 Apr; 50(2):354-8. PubMed ID: 24506425
[TBL] [Abstract][Full Text] [Related]
31. Potential Facilitation Between a Commensal and a Pathogenic Microbe in a Wildlife Disease.
Sandmeier FC; Leonard KL; Weitzman CL; Tracy CR
Ecohealth; 2022 Sep; 19(3):427-438. PubMed ID: 35752710
[TBL] [Abstract][Full Text] [Related]
32. Bilateral palpebral reduction and concurrent mycoplasmosis in a wild Agassiz's desert tortoise (Gopherus agassizii).
Jacobson ER; Berry KH; Brooks DE; Roberts JF
Vet Ophthalmol; 2023 Jul; 26(4):361-366. PubMed ID: 37030880
[TBL] [Abstract][Full Text] [Related]
33. Upper respiratory tract disease, force of infection, and effects on survival of gopher tortoises.
Ozgul A; Oli MK; Bolker BM; Perez-Heydrich C
Ecol Appl; 2009 Apr; 19(3):786-98. PubMed ID: 19425439
[TBL] [Abstract][Full Text] [Related]
34. Effects of mycoplasmal upper-respiratory-tract disease on movement and thermoregulatory behavior of gopher tortoises (Gopherus polyphemus) in Georgia, USA.
McGuire JL; Smith LL; Guyer C; Yabsley MJ
J Wildl Dis; 2014 Oct; 50(4):745-56. PubMed ID: 25121399
[TBL] [Abstract][Full Text] [Related]
35. High quality draft genome sequences of
Alvarez-Ponce D; Weitzman CL; Tillett RL; Sandmeier FC; Tracy CR
Stand Genomic Sci; 2018; 13():12. PubMed ID: 29725499
[No Abstract] [Full Text] [Related]
36. Assessing spatial distribution, genetic variants, and virulence of pathogen
Bauschlicher SN; Weitzman CL; Martinez V; Tracy CR; Alvarez-Ponce D; Sandmeier FC
Ecol Evol; 2023 Jun; 13(6):e10173. PubMed ID: 37284665
[TBL] [Abstract][Full Text] [Related]
37. Serologic and molecular evidence for Testudinid herpesvirus 2 infection in wild Agassiz's desert tortoises, Gopherus agassizii.
Jacobson ER; Berry KH; Wellehan JF; Origgi F; Childress AL; Braun J; Schrenzel M; Yee J; Rideout B
J Wildl Dis; 2012 Jul; 48(3):747-57. PubMed ID: 22740541
[TBL] [Abstract][Full Text] [Related]
38. Mycoplasma agassizii, an opportunistic pathogen of tortoises, shows very little genetic variation across the Mojave and Sonoran Deserts.
Luzuriaga-Neira A; Sandmeier FC; Weitzman CL; Tracy CR; Bauschlicher SN; Tillett RL; Alvarez-Ponce D
PLoS One; 2021; 16(2):e0245895. PubMed ID: 33534823
[TBL] [Abstract][Full Text] [Related]
39. Mycoplasma testudineum sp. nov., from a desert tortoise (Gopherus agassizii) with upper respiratory tract disease.
Brown DR; Merritt JL; Jacobson ER; Klein PA; Tully JG; Brown MB
Int J Syst Evol Microbiol; 2004 Sep; 54(Pt 5):1527-1529. PubMed ID: 15388705
[TBL] [Abstract][Full Text] [Related]
40. Flow cytometric method for quantifying viable Mycoplasma agassizii, an agent of upper respiratory tract disease in the desert tortoise (Gopherus agassizii).
Mohammadpour HA; Tracy CR; Redelman D; duPre' SA; Hunter KW
Lett Appl Microbiol; 2010 Apr; 50(4):347-51. PubMed ID: 20132436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
